Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05714033 · ClinicalTrials.gov registry record · NA
A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)
A NA study of Pulmonary and Lung, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05714033 is a NA study of Pulmonary and Lung that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05714033, a NA study of Pulmonary and Lung, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.
Interventions
- PROCEDURE Ventilatory Strategy To Prevent Atelectasis
- PROCEDURE Lateral Decubitus Strategy (LADS)
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-02-10 |
| Est. Completion | 2032-09-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05714033
The ClinicalTrials.gov registry entry for NCT05714033 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary appearing as the primary indexed condition, and to 2 interventions - of which Ventilatory Strategy To Prevent Atelectasis is the first listed.
NCT05714033 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05714033 about?
NCT05714033 is a clinical study titled "A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)". To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.
What is the current status of trial NCT05714033?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-02-10. Estimated completion is 2032-09-14.
What conditions does trial NCT05714033 study?
This clinical trial studies the following conditions: Pulmonary, Lung.
What interventions are being tested in trial NCT05714033?
The interventions under investigation include: Ventilatory Strategy To Prevent Atelectasis (PROCEDURE), Lateral Decubitus Strategy (LADS) (PROCEDURE).
Who is sponsoring clinical trial NCT05714033?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05714033 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.